These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1355790)

  • 1. Prediction of affected MEN2A gene carriers by DNA linkage analysis for early total thyroidectomy: a progress in clinical screening program for children with hereditary cancer syndrome.
    Shimotake T; Iwai N; Yanagihara J; Tokiwa K; Tanaka N; Yamamoto M; Takai S
    J Pediatr Surg; 1992 Apr; 27(4):444-6. PubMed ID: 1355790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
    Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
    N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical implications of a positive calcitonin test for C-cell hyperplasia in genetically unaffected members of an MEN2A kindred.
    Landsvater RM; Rombouts AG; te Meerman GJ; Schillhorn-van Veen JM; Berends MJ; Geerdink RA; Struyvenberg A; Buys CH; Lips CJ
    Am J Hum Genet; 1993 Feb; 52(2):335-42. PubMed ID: 8094268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a screening program for multiple endocrine neoplasia type 2A: a clinical study of a Japanese family.
    Shimotake T; Iwai N; Yanagihara J; Kobayashi T; Takai S
    Henry Ford Hosp Med J; 1989; 37(3-4):124-6. PubMed ID: 2576943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presymptomatic identification of carriers of the multiple endocrine neoplasia type 2A gene using flanking DNA markers.
    Howe JR; Lairmore TC; Dou S; Mishra SK; Dilley WG; Donis-Keller H; Wells SA
    Surgery; 1992 Aug; 112(2):219-25; discussion 225-6. PubMed ID: 1353639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical detection of MEN 2A gene carrier using linked DNA markers.
    Tanaka N; Yamamoto M; Miki T; Okazaki M; Sakita I; Shimotake T; Kobayashi T; Miyauchi A; Mori T; Takai S
    Jinrui Idengaku Zasshi; 1991 Jun; 36(2):165-70. PubMed ID: 1681126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new DNA marker (D10S94) very tightly linked to the multiple endocrine neoplasia type 2A (MEN2A) locus.
    Goodfellow PJ; Myers S; Anderson LL; Brooks-Wilson AR; Simpson NE
    Am J Hum Genet; 1990 Dec; 47(6):952-6. PubMed ID: 1978561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a screening program for multiple endocrine neoplasia type II.
    Fletcher DR; Gamvros O; MacFarlane A; Ward-McQuaid JN; Lynn J
    Surg Gynecol Obstet; 1984 Aug; 159(2):119-26. PubMed ID: 6147022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutations of the RET proto-oncogene in pedigree with MEN type 2A: DNA analysis and its implications for pediatric surgery.
    Shimotake T; Iwai N; Inoue K; Inazawa J; Nishisho I
    J Pediatr Surg; 1996 Jun; 31(6):779-81. PubMed ID: 8783101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
    Wells SA; Chi DD; Toshima K; Dehner LP; Coffin CM; Dowton SB; Ivanovich JL; DeBenedetti MK; Dilley WG; Moley JF
    Ann Surg; 1994 Sep; 220(3):237-47; discussion 247-50. PubMed ID: 7916559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with a provocative test of calcitonin release as a prospective screening for preclinical medullary thyroid carcinoma in MEN type 2A family members.
    van Lathem JJ; Vermaak WJ; Kuyl JM; Mollentze W; Jansen S; Wolmarans L; Pelser H; Barry R; Kruger AJ; Wolfaardt M
    J Clin Lab Anal; 1992; 6(6):384-90. PubMed ID: 1359042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.
    McMahon R; Mulligan LM; Healey CS; Payne SJ; Ponder M; Ferguson-Smith MA; Barton DE; Ponder BA
    Hum Mol Genet; 1994 Apr; 3(4):643-6. PubMed ID: 7915166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis.
    Lamothe EM; Narod SA; Miller S; Goodfellow PJ; Cole DE; Gilchrist D; Pausova Z; Goltzman D; Hendy GN
    Henry Ford Hosp Med J; 1992; 40(3-4):224-6. PubMed ID: 1362410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative Group.
    Mathew CG; Easton DF; Nakamura Y; Ponder BA
    Lancet; 1991 Jan; 337(8732):7-11. PubMed ID: 1670689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Decker RA
    Surgery; 1993 Dec; 114(6):1059-63. PubMed ID: 7903002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.